• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[集落形成试验在卵巢癌中的意义]

[Significance of the colony formation test in ovarian carcinoma].

作者信息

Runge H M, Bücke W, Neumann H A

出版信息

Onkologie. 1984 May;7 Suppl 2:66-73. doi: 10.1159/000215518.

DOI:10.1159/000215518
PMID:6235468
Abstract

Methods and evaluation of the human tumor stem cell assay (HTSCA) are described. Advantages and disadvantages of the test system are elaborated. The in vitro/in vivo correlation in the drug screening of human ovarian carcinomas shows that the prediction of sensitivity to a cytotoxic agent is only possible in 64%. Prediction of drug resistance, however, seems to be possible in 95%. The number of patients that profit from the HTSCA seems to be only less than 10%. Our investigations describe the influence of various hormones and antiestrogens on the colony formation of human ovarian carcinoma cells. Tamoxifen and his major metabolite 4-hydroxy-tamoxifen were the most active agents. Both compounds inhibit the colony survival (70% at pharmacological concentrations) of 60% of the screened ovarian carcinomas. A significant correlation to the quantitative level of estrogen or progesterone receptors could not be proved. Colony formation of ovarian carcinoma cells was compared in the HTSCA as described by Hamburger and Salmon and in a methylcellulose-monolayer system. Our results show that the colony formation corresponds to the results of the original HTSCA: Cloning ovarian carcinoma cells in the methylcellulose-monolayer, however, seems to be technically easier and faster.

摘要

本文描述了人类肿瘤干细胞检测法(HTSCA)的方法及评估。阐述了该检测系统的优缺点。人类卵巢癌药物筛选中的体外/体内相关性表明,对细胞毒性药物敏感性的预测仅有64%的可能性。然而,耐药性的预测似乎有95%的可能性。从HTSCA中获益的患者数量似乎仅不到10%。我们的研究描述了各种激素和抗雌激素对人类卵巢癌细胞集落形成的影响。他莫昔芬及其主要代谢物4-羟基他莫昔芬是最具活性的药物。这两种化合物可抑制60%的筛查卵巢癌的集落存活(在药理浓度下为70%)。未能证明与雌激素或孕激素受体的定量水平存在显著相关性。在HTSCA中,按照Hamburger和Salmon的方法,以及在甲基纤维素单层系统中,对卵巢癌细胞的集落形成进行了比较。我们的结果表明,集落形成与原始HTSCA的结果一致:然而,在甲基纤维素单层中克隆卵巢癌细胞在技术上似乎更容易、更快。

相似文献

1
[Significance of the colony formation test in ovarian carcinoma].[集落形成试验在卵巢癌中的意义]
Onkologie. 1984 May;7 Suppl 2:66-73. doi: 10.1159/000215518.
2
Cloning ovarian carcinoma cells in an agar double layer versus a methylcellulose monolayer system. A comparison of two methods.在琼脂双层与甲基纤维素单层系统中克隆卵巢癌细胞。两种方法的比较。
J Cancer Res Clin Oncol. 1985;110(1):51-5. doi: 10.1007/BF00402502.
3
In vitro responsiveness of ovarian epithelial carcinomas to endocrine therapy.卵巢上皮癌对内分泌治疗的体外反应性。
Cancer Chemother Pharmacol. 1986;16(1):58-63. doi: 10.1007/BF00255287.
4
The effects of estrogen, progesterone, and tamoxifen alone and in combination with cytotoxic agents against human ovarian carcinoma in vitro.雌激素、孕激素及他莫昔芬单独及与细胞毒性药物联合应用对人卵巢癌的体外作用。
Cancer. 1990 Mar 1;65(5):1055-61. doi: 10.1002/1097-0142(19900301)65:5<1055::aid-cncr2820650502>3.0.co;2-9.
5
Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.在软琼脂克隆形成试验中对人乳腺癌进行内分泌治疗检测。
Breast Cancer Res Treat. 1985;6(3):229-35. doi: 10.1007/BF01806773.
6
[Hormone dependence of malignant ovarian tumors--an in vitro model].[恶性卵巢肿瘤的激素依赖性——一种体外模型]
Geburtshilfe Frauenheilkd. 1989 May;49(5):437-41. doi: 10.1055/s-2008-1036398.
7
[Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Wien Klin Wochenschr Suppl. 1990;183:3-29.
8
Limitations of drug sensitivity testing in soft agar for clinical management of patients with ovarian carcinoma.用于卵巢癌患者临床管理的软琼脂药敏试验的局限性。
Obstet Gynecol. 1985 Jul;66(1):115-20.
9
Steroid receptors and response of ovarian cancer to hormones in vitro.类固醇受体与卵巢癌在体外对激素的反应
Br J Obstet Gynaecol. 1984 May;91(5):472-8. doi: 10.1111/j.1471-0528.1984.tb04786.x.
10
[Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
Geburtshilfe Frauenheilkd. 1985 Jul;45(7):477-81. doi: 10.1055/s-2008-1036356.